Globus Medical (GMED) Change in Accured Expenses (2011 - 2026)

Globus Medical (GMED) has 16 years of Change in Accured Expenses data on file, last reported at -$24.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 13.92% year-over-year to -$24.7 million; the trailing twelve-month figure through Mar 2026 stood at $38.2 million (up 272.9% YoY), and the FY2025 full-year result was $34.2 million, up 581.21% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$24.7 million, down from $8.8 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $39.3 million in Q3 2025 and bottomed at -$33.9 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $4.9 million (2024), against an average of $2.2 million.
• Peak annual rise in Change in Accured Expenses reached 234.24% in 2024, while the deepest fall reached 239.86% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $4.4 million in 2022, then plunged by 177.98% to -$3.5 million in 2023, then jumped by 234.24% to $4.6 million in 2024, then surged by 89.36% to $8.8 million in 2025, then tumbled by 381.12% to -$24.7 million in 2026.
• The last three Change in Accured Expenses figures came in at -$24.7 million (Q1 2026), $8.8 million (Q4 2025), and $39.3 million (Q3 2025), per Business Quant data.

Peer Comparison